Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$242.49 - $301.46 $5.92 Million - $7.36 Million
-24,425 Reduced 10.44%
209,427 $51.4 Million
Q2 2022

Aug 12, 2022

BUY
$224.73 - $338.64 $6.58 Million - $9.91 Million
29,258 Added 14.3%
233,852 $57.9 Million
Q1 2022

May 16, 2022

BUY
$277.25 - $366.29 $461,344 - $609,506
1,664 Added 0.82%
204,594 $67.8 Million
Q4 2021

Feb 08, 2022

SELL
$300.63 - $371.35 $8.86 Million - $10.9 Million
-29,467 Reduced 12.68%
202,930 $72.9 Million
Q3 2021

Nov 15, 2021

BUY
$310.19 - $376.2 $7.91 Million - $9.59 Million
25,495 Added 12.32%
232,397 $75.6 Million
Q2 2021

Sep 13, 2021

BUY
$262.71 - $351.17 $54.4 Million - $72.7 Million
206,902 New
206,902 $64.6 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.